Vistagen.com

  1. Home
  2. Vistagen.com

Developing Innovative Medications for the Central …

WebOur Vision Striving for a world no longer gripped by anxiety and depression. Vistagen’s core goal is to radically improve mental health and well-being worldwide. In developing safe …

Actived: 5 days ago

URL: https://www.vistagen.com/

Major Depressive Disorder Vistagen Therapeutics, Inc

WebDepression is a serious medical illness and a global public health concern that can occur at any time over a person's life. According to the World Health Organization, depression is …

Category:  Medical Go Health

Social Anxiety Disorder Vistagen Therapeutics, Inc

WebSocial Anxiety Disorder. Based on the 2021 National Health and Wellness Survey, social anxiety disorder (SAD) affects over 25 million Americans, with onset typically in the mid …

Category:  Health Go Health

AV-101, an Oral NMDR Glycine Site Antagonist for Depression and

WebAV-101 (4-Cl-KYN) is an investigational oral prodrug that targets the N-methyl-D-aspartate receptor (NMDAR), an ionotropic glutamate receptor in the brain.

Category:  Health Go Health

VistaGen Announces Completion of PALISADE-1 Phase 3 Clinical …

WebPALISADE Phase 3 Program focused on PH94B’s potential as a rapid-onset, acute treatment of anxiety in adults with social anxiety disorder FDA Fast Track designation …

Category:  Health Go Health

Our Purpose, Our Vision

WebThese core values guide our internal processes and define our mission to radically improve mental health and well-being worldwide. Vistagen Therapeutics’ core goal is to radically …

Category:  Health Go Health

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the …

WebKey study underway in registration-directed PALISADE Phase 3 program for fasedienol in social anxiety disorder Social anxiety disorder affects over 25 million Americans SOUTH …

Category:  Health Go Health

Vistagen Awarded Mental Health America’s Platinum Bell Seal for

WebMental Health America’s prestigious national certification complements Vistagen’s ongoing efforts to improve mental health care across the U.S. Timely recognition comes during …

Category:  Health Go Health

PH80 Overview Vistagen Therapeutics, Inc

WebPH80 Overview. PH80 is an odorless, tasteless synthetic investigational pherine with a novel, rapid-onset proposed mechanism of action (MOA) with potential to treat multiple …

Category:  Health Go Health

PH15 Overview Vistagen Therapeutics, Inc

WebPH15 Overview. Acute Treatment for Improvement of Cognition. PH15 is an investigational pherine nasal spray with a novel, rapid-onset potential mechanism of action (MOA) that …

Category:  Health Go Health

Vistagen Announces Positive Top-Line Results from Phase 3 …

WebFirst positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years. Statistically si gnificant rapid-onset reduction in patient-reported …

Category:  Health Go Health

Investors Vistagen Therapeutics, Inc

WebCompany Profile. Vistagen (Nasdaq: VTGN) is a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric …

Category:  Health Go Health

Vistagen to Acquire Pherin Pharmaceuticals Vistagen …

WebVistagen’s acquisition of Pherin will eliminate all future royalty and milestone payment obligations related to PH94B and PH10 and add three new pherine drug candidates to …

Category:  Health Go Health

Vistagen to Present at Stifel 2023 Healthcare Conference

WebSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 8, 2023-- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the …

Category:  Health Go Health

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and

WebFasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on track PALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4 trial …

Category:  Health Go Health

Vistagen to Present at Stifel 2024 Virtual CNS Days Vistagen

WebSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar. 11, 2024-- Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver …

Category:  Health Go Health

Vistagen to Present Positive Fasedienol Phase 3 Data and Positive …

WebPositive top-line results from fasedienol (PH94B) Phase 3 PALISADE-2 trial in social anxiety disorder (SAD) to be presented by SAD expert, Dr. Michael Liebowitz, at CNS Summit …

Category:  Health Go Health

Stifel 2023 Healthcare Conference Vistagen Therapeutics, Inc

WebStifel 2023 Healthcare Conference. Nov 14 - Nov 15, 2023. Presentation to take place Tuesday, November 14 at 1:15 p.m. Eastern Time. Webcast.

Category:  Health Go Health

Morgan Stanley 20th Annual Global Healthcare Conference

WebMorgan Stanley 20th Annual Global Healthcare Conference. Sep 13 - Sep 14, 2022.

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Ballad health physician salary

 › Rural health clinic covid testing

 › Personal care home health

 › Ou health sign in page

 › Mills health center parking

 › Ssm health careers shawnee ok

 › Union health services management plan

 › Global health internal medicine

 › Health net llc scam

 › Interprofessional communication in health care

Recently Searched

 › Disaster planning in health care

 › How is social media good for your mental health

 › Health south rehab toms river

 › Heart healthy printable food list

 › Health south rehab round rock

 › Boyle county health department ky

 › Healthcare administration degree vonore tennessee

 › Health and safety childcare policy

 › Healthy and unhealthy teenage relationships

 › Virtual health log in